The generation of nfkb2 p52: mechanism and efficiency
- PMID: 10597218
- DOI: 10.1038/sj.onc.1203022
The generation of nfkb2 p52: mechanism and efficiency
Abstract
nfkb2 encodes two members of the NF-kappa B/Rel family of proteins: p52 and p100. The p100 polypeptide has been proposed to serve as a precursor of p52, which corresponds to the N-terminal half of p100. While p52 functions as a Rel transcription factor, the larger p100 protein acts as a cytoplasmic inhibitor of select NF-kappa B/Rel transcription factor complexes. Because of their distinct functions, we have studied the biochemical basis for the production of these two nfkb2-derived gene products. Like the p50 product of the nfkb1 gene, p52 is principally generated in a cotranslational manner involving proteolytic processing by the proteasome. The generation of p52 is dependent on a glycine-rich region (GRR) located upstream of the p52 C-terminus, and repositioning of this GRR alters the location of proteasome processing. In most cells, small amounts of p52 are produced relative to the levels of p100, unlike the usually balanced production of nfkb1-derived p50 and p105. Using p100/p105 chimeras containing different segments of the nfkb1 and nfkb2 genes, we have found that diminished p52 processing is a property conferred by peptide sequences located downstream of the GRR, flanking the site of p52 processing.
Similar articles
-
The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.Genomics. 1995 Dec 10;30(3):493-505. doi: 10.1006/geno.1995.1270. Genomics. 1995. PMID: 8825636
-
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.Oncogene. 1994 Mar;9(3):923-33. Oncogene. 1994. PMID: 8108136
-
Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.Oncogene. 1994 Mar;9(3):841-52. Oncogene. 1994. PMID: 8108127
-
The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.Biochem Pharmacol. 2006 Oct 30;72(9):1161-79. doi: 10.1016/j.bcp.2006.08.007. Epub 2006 Sep 12. Biochem Pharmacol. 2006. PMID: 16970925 Review.
-
A role for NF-kappaB and the proteasome in autoimmunity.Arch Immunol Ther Exp (Warsz). 2000;48(5):353-65. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140462 Review.
Cited by
-
Signaling Pathway Mediating Myeloma Cell Growth and Survival.Cancers (Basel). 2021 Jan 8;13(2):216. doi: 10.3390/cancers13020216. Cancers (Basel). 2021. PMID: 33435632 Free PMC article. Review.
-
Single-Cell Analysis of Alternative Splicing and Gene Regulatory Network Reveals Remarkable Expression and Regulation Dynamics During Human Early Embryonic Development.FASEB Bioadv. 2025 Jul 9;7(7):e70036. doi: 10.1096/fba.2025-00075. eCollection 2025 Jul. FASEB Bioadv. 2025. PMID: 40641848 Free PMC article.
-
Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.EMBO Rep. 2003 Jan;4(1):82-7. doi: 10.1038/sj.embor.embor710. EMBO Rep. 2003. PMID: 12524526 Free PMC article.
-
p52 signaling promotes cellular senescence.Cell Biosci. 2022 Apr 4;12(1):43. doi: 10.1186/s13578-022-00779-6. Cell Biosci. 2022. PMID: 35379326 Free PMC article.
-
Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.Mol Cell Biol. 2004 Jan;24(1):475-86. doi: 10.1128/MCB.24.1.475-486.2004. Mol Cell Biol. 2004. PMID: 14673179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous